HEXTAR Healthcare Bhd reported a net loss of RM3.5 million for the first quarter ended March 31, 2025 (1QFY2025), reversing a net profit of RM632,000 a year earlier.
The loss was attributed to lower sales revenue and higher costs stemming from underutilisation of its production plant.
Quarterly revenue fell 6.69% to RM37.63 million from RM40.32 million in the same period last year.
In a filing with Bursa Malaysia, its MD Khoo Chin Leng said the company remains cautiously optimistic as the glove market gradually normalises, despite ongoing global trade and supply chain uncertainties, particularly from U.S. tariff policies.
He acknowledged that current soft demand and weak pricing may persist in the short to medium term.
Despite the challenging outlook, Khoo affirmed the group’s commitment to becoming a leading healthcare industry player through continuous innovation and growth.
Hextar Healthcare’s shares closed 9.09% higher at 12 sen TODAY, giving it a market capitalisation of RM143.2 million. –TMR
The post Hextar Healthcare swings to RM3.5m loss in 1Q on lower sales, higher costs appeared first on The Malaysian Reserve.
